We’re the leading resource for those affected by bleeding disorders. You can count on our organization to ensure your voice is heard. It’s with your help that we can make a difference. Learn more and get involved.
The therapy is for patients with severe and moderately severe hemophilia B.
These activities are the product of a collaboration between Medscape, NHF, the European Haemophilia Consortium and the World Federation of Hemophilia.
This new study will investigate if new therapies have resulted in better outcomes related to brain function in young hemophilia patients.
The winner of the 2018 MLB's Player's Choice Comeback Player of the Year Award selected NHF as his designated charity.
Subscribe to Our Newsletter
Fill in the fields below to receive our email newsletter.